Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Dr. Mark Hawass Celebrates Global Awards for Groundbreaking Arthritis Treatments

by
October 3, 2024
in Economy, Investing
0
Dr. Mark Hawass Celebrates Global Awards for Groundbreaking Arthritis Treatments
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Last Updated on:

Dr Mark Hawass, the visionary behind Arthritis VIP, has earned widespread recognition in the medical field, securing two major awards in 2024: the Global Recognition Award and the Innovation Award from Big Business Events. These honours celebrate his pioneering approach to arthritis treatment.

Dr Hawass’s VIP Biohacking Method, a non-surgical, patient-first approach, has provided life-changing relief to thousands of people suffering from chronic pain, particularly across Canada. His methods are considered revolutionary for arthritis treatment.

In celebrating the fifth anniversary of Arthritis VIP, the clinic has successfully transformed the lives of more than 1,300 patients, thanks to the innovative VIP Biohacking Method. Unlike conventional treatments, this method addresses the underlying causes of joint pain and inflammation, providing long-lasting relief without the need for surgery. Arthritis VIP has therefore become a global leader in non-surgical arthritis care.

Central to Dr Hawass’s approach is a commitment to offering a VIP experience for each patient. Arthritis VIP ensures same-day appointments and a maximum two-hour response time, providing every patient with personalised care.

“Our approach is all about giving patients the time and attention they deserve. Every consultation is in-depth, and each treatment plan is meticulously tailored to deliver real, lasting relief,” said Dr Hawass.

Beyond the initial treatment, Dr Hawass tracks patient progress for two years to refine the VIP Biohacking Method. With cutting-edge regenerative techniques, Arthritis VIP delivers long-term pain relief, helping patients regain their quality of life.

Winning both the UK Innovation Award and the Global Recognition Award acknowledges Dr Hawass’s contributions on an international scale, representing a milestone achievement for him and his team.

“These awards are a testament to our dedication to advancing non-surgical treatments for arthritis and chronic pain. We’re pushing the boundaries of what’s possible in this field with the VIP Biohacking Method,” said Dr Hawass.

The awards not only honour Dr Hawass’s achievements but also affirm the world-class care Arthritis VIP provides. For patients struggling with arthritis and chronic pain, these accolades reflect the top-tier treatment and compassionate care they can expect under his leadership.

“These awards are dedicated to our patients – they are proof that we’re delivering the highest level of care. Our goal is to help even more people across Canada overcome pain and regain their quality of life, and we’re not stopping here,” Dr Hawass added.

Alex Sterling, spokesperson for the Global Recognition Awards, commented: “Dr Hawass’s VIP Biohacking Method is a true game-changer. His ability to blend advanced medical techniques with a compassionate, patient-centred approach sets a new benchmark in arthritis care. These awards are well-deserved recognition of his innovation and impact.”

As Arthritis VIP continues to expand, the clinic remains focused on transforming arthritis care with the VIP Biohacking Method, improving patient outcomes, and helping more individuals across Canada live pain-free. With Dr Hawass at the helm, the future of arthritis treatment is more promising than ever.

ShareTweetPin

Related Posts

Angkor Resources: Unlocking Cambodia’s Resource Potential through Energy and Minerals Assets
Investing

Angkor Resources: Unlocking Cambodia’s Resource Potential through Energy and Minerals Assets

September 16, 2025
Alice Queen raises $1M via issue of Convertible Notes
Investing

Alice Queen raises $1M via issue of Convertible Notes

September 16, 2025
Barrick’s Plan to Sell Hemlo Mine for US$1.09 Billion Marks Canadian Exit
Investing

Barrick’s Plan to Sell Hemlo Mine for US$1.09 Billion Marks Canadian Exit

September 15, 2025
Prismo Metals Identifies Porphyry Style Mineralization at Silver King
Investing

Prismo Metals Identifies Porphyry Style Mineralization at Silver King

September 15, 2025
Editor’s Picks: Gold Knocks Out Inflation-Adjusted High, Silver Breaks US$42
Investing

Editor’s Picks: Gold Knocks Out Inflation-Adjusted High, Silver Breaks US$42

September 13, 2025
Top 5 Canadian Mining Stocks This Week: Guardian Exploration Gains 94 Percent
Investing

Top 5 Canadian Mining Stocks This Week: Guardian Exploration Gains 94 Percent

September 13, 2025
Next Post
EcoGreen Electrical & EV Ltd Reaches 1000th EV Charger Installation Milestone

EcoGreen Electrical & EV Ltd Reaches 1000th EV Charger Installation Milestone

Recommended

PHL obtains $501M in ADB funding to boost job quality, infra support 

PHL obtains $501M in ADB funding to boost job quality, infra support 

December 22, 2024
Bangko Sentral ng Pilipinas: Declaring Independence

Bangko Sentral ng Pilipinas: Declaring Independence

September 29, 2024
IC looks to set valuation standards for MBAs’ required policy reserves

IC looks to set valuation standards for MBAs’ required policy reserves

December 30, 2024
Cebu Pacific adds three more aircraft

Cebu Pacific adds three more aircraft

October 31, 2024
OP gets P5B more for ASEAN Summit chairmanship in 2026

OP gets P5B more for ASEAN Summit chairmanship in 2026

December 30, 2024
Malta Citizenship vs Permanent Residence vs Residence Permit: What to Choose?

Malta Citizenship vs Permanent Residence vs Residence Permit: What to Choose?

October 9, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved